The Community Medicine of Cerebrovascular Disease
Introduction
• In the coming years most clinicians will continue to be concerned primarily with doing their best for individual patients. In 1970, however, a second concern has also emerged, partly pushed by consumer groups and protesting medical students, and seeking to answer how each health worker may have his greatest impact on the burden of disease in his community. It reinforces the view that something more than good private practice and individual patient care is needed to help further those sections of society with the most disease.
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lem, but whose emotional attachments lie in other disease and population groups; these feelings may continue to dominate in future planning. All groups have also met the obstacle, however, that the scarce incidence figures for cerebrovascular disease have an uncertain basis, are too weak to neutralize emotional hurdles, and are difficult to translate into future control activities. To help alleviate these latter problems, the purpose of this paper is to analyze recent morbidity figures for cerebrovascular disease, to assess the response of this disease group to current arrangements for treatment, and to suggest what these figures imply for improving the arrangements for stroke care in American communities.
Incidence Rates for Cerebrovascular Disease
Death rates are often used in health planning, primarily because of their ready availability and partly because they may also relate to the annual number of new cases occurring in the population, usually termed the incidence rate. In contrast to mortality data, however, incidence figures originate closer to the onset of disease in the living population, include survivors as well as those who die, and should give a truer picture of community health problems. Incidence rates for cerebrovascular disease are much affected by the age and race distribution of the population. This section will review the influence particularly of these factors.
Much discussion has focused on the formation of systems to encourage the voluntary reporting of cases to a "stroke registry," similar to those developed in past years for cancer, tuberculosis, rheumatic fever, and other disease groups.
1 Some stroke registries have been established in the U.S.A., but have not matured sufficiently by 1970 to give information of use to other areas.
In recent years, however, small population groups have been studied which give clues to the incidence of cerebrovascular disease. A short-term study was completed during 1957 to 1958, when Eisenberg et al. 2 surveyed the incidence of new cerebrovascular disease in Middlesex County, Connecticut; its population of 83,500 was almost entirely white. Obtaining their case reports from physicians, death certificates, hospital reports, and nursing 386 homes, the authors followed the 191 new patients for five years. The resulting annual incidence rate was 2.3 per 1,000 population, rising for all diagnoses with advancing age. This study omitted transient ischemic attacks and cases with symptoms lasting two days or less, the addition of which would have moderately raised the incidence figures.
A similar study, performed in three midMissouri counties during 1963 to 1965, monitored a population of about SO^O.
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The case reports came from physicians, nursing homes, hospitals, death certificate files, and local health departments. Cerebrovascular disease developed in 410 persons in the first two years of study. The annual incidence rates were 2.4 per 1,000 whites and about four per 1,000 nonwhites. While the latter figure had a large potential error because of the small population and few cases on which it was based, the midMissouri study is our sole source of estimates for nonwhite incidence rates, which will be discussed later in this review. Transient ischemic attacks were again omitted from this study.
Incidence figures have also been published recently following 14 years of experience in the prospective study in Framingham, Massachusetts. 8 The investigators in Framingham have closely followed the cerebrovascular disease experience of about 5,000 men and women, aged 30 to 62 at the time of entry into the study, who were found free of the disease group at that time. Medical examinations, given every two years, have documented a total of 133 cases of cerebrovascular disease during the first 14 years. Table 1 shows that the agespecific incidence figures from Framingham are reasonably compatible with those from the previous two studies.
The three investigations mentioned above began by defining the group to be studied and by collecting information on new cases as they occurred in the population. In contrast to this "prospective" method, Kurland et al. 7 ' 8 carried out a "retrospective" study of cases obtained from the records of Mayo Clinic physicians, who treated patients from Rochester, Minnesota, and surroundng Olmsted County. The 64 new cases in 1957 had been cared for at home, in local hospitals, or in the Mayo Clinic, and were believed to form almost all new cases in that geographical region. The incidence Brewis et al. 9 formed another group which carried out a retrospective search of hospital records, general practitioner records, and death certificates for 1955 to 1961 in the English town of Carlisle. They clarified that the minimum annual incidence of cerebrovascular disease was close to three per 1,000 population during the seven-year period. This study paid special attention to the annual incidence of subarachnoid hemorrhage, as did Crawford and Sarner 10 in England and Pakarinen 11 in Finland; this seems likely to lie below 20 per 100,000 population in most areas.
How can the above studies help planning groups estimate the number of new cases of cerebrovascular disease in their own areas? Since no single study had such extensive experience that its figures deserve to be used alone, I have combined the experience of four studies to calculate approximate age-specific incidence rates given in the lower part of table 1. When applied to the age groups in populations which are mainly white, these rates will give an estimate of new cases which is more accurate than that obtained by applying arbitrary numbers, such as 2.5 or 3 per 1,000, to the total population. The resulting figures are still estimates, however, and may have to be supported eventually by figures derived from the population being planned for.
The incidence figures in table 1 will underestimate the frequency of cerebrovascular disease in nonwhite populations. Only the mid-Missouri study, which involved a small nonwhite group, gives clues to the higher rates which affect Negroes. Summarizing these preliminary data, table 2 shows that nonwhite rates seem to be more than double those of whites under 75 years, and only moderately higher than whites above that age. Until more definitive information becomes available, we may be wise to estimate that nonwhite cases of cerebrovascular disease will be at least 50% more numerous than those arising from a white population of the same size and age. Data from references 3 to 5.
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Figures from Medical Care Programs
Since the special studies described above have been expensive and few, we must also use the less reliable figures from medical care programs, which have analyzed their experience by disease groups, to study the distribution of cerebrovascular disease. Such analyses must be interpreted with caution, realizing that the data are formed primarily to improve the administration of the program, and only secondarily to contribute to new knowledge. •Includes one case of unknown age. tPer million person-years of experience in the Plan.
Data from reference 12. sufficiently consistent or large to require consideration by planning groups. Also in Canada, LeRiche, Bond and Stiver 13 analyzed with considerable difficulty the 1963 experience of Physicians Services Incorporated in Ontario. This voluntary, prepaid plan paid for physicians' services in the hospital, office, and home. Older persons were underrepresented among the population and industrial groups covered; thus only 2.3% were 65 years and older. In this relatively young population, the annual incidence of cerebrovascular disease was 2.2 per 1,000 men and 2 per 1,000 women. The age-specific rates for the sample of participants (table 4) were higher than the equivalent rates for the Plan in British Columbia, possibly relating to the lower socioeconomical status of the Ontario groups.
HOSPITAL-BASED STUDIES
A further group of helpful figures come from the hospital experience of whole communities. When compared with patients not admitted to the hospital, hospital-based figures for cerebrovascular disease will include the younger but more seriously ill cases, and should involve diagnoses of better quality than those made at home or in other institutions. Most data from hospitals do involve the problem of doublecounting of patients admitted more than once in the same year for the same disease. This problem may be smaller than average for patients with cerebrovascular disease. Many die on first admission and are no longer available for repeat admissions. Those who survive the first admission are less acceptable for hospital care when the second stroke occurs.
Most hospital systems with diagnostic data have shown a rise in discharge rates for cerebrovascular disease in recent years. For example, the Saskatchewan rate for men has risen from 1.71 per 1,000 male population in 1952 to 1953 to 2.52 in 1967. The rate for men in England and Wales has risen from 1.24 in 1957 to 1958 to 1.62 in 1966. This change probably results from an increasing acceptability of older patients with cerebrovascular disease to be admitted for hospital care, and probably not from a true rise in incidence of disease. Table 4 contrasts the age-specific hospital discarge rates for patients in four geographical areas. It shows that the SaskatchStrok; Vol. 1, Navmber-Defmbtr 1970 ewan figures resemble closely the incidence figures for Middlesex County and mid-Missouri, and for four areas combined, which were given in table 1. The generous supply of acute beds and the paucity of long-term beds in Saskatchewan probably help most patients with cerebrovascular disease to enter its hospitals. In contrast, the lower rates for England and Wales, and particularly for Scotland whose death rates are so high for stroke, suggest that these areas raise barriers to prevent the hospitalization of older patients. Many physicians and planning groups may support these barriers, rightly or wrongly, but clearly the extent to which incidence figures approach hospitalization figures will depend partly on the decisions which planning groups make about the supply of hospital beds in their communities.
PREVALENCE RATIO FIGURES
Incidence rates reflect the annual new cases of cerebrovascular disease occurring in a community, and program planners should give priority to the prompt care of cases of recent onset. Of lesser value in planning are prevalence ratios, describing the frequency of disease existing at one moment in time. These figures reflect the community backlog of cases, both of recent and of distant onset. Although planning groups pay attention to prevalence figures, they must acknowledge that programs will rarely expand so generously that they care for the backlog as well as for the new cases.
In the U.S.A., the continuing National Health Survey has improved our information on prevalence of cerebrovascular disease. During 1963 to 1965, for example, this survey found 2.8 persons with some degree of paralysis due to cerebrovascular disease per 1,000 population 14 ; about 519,000 persons were thus estimated to form this group. Probably the nation's population had an equal number of persons who were unimpaired by their disease, 16 but who were exposed to the high risk of recurrence. To be added to these figures were the 188,100 residents of nursing and personal-care homes found in 1964 to have had cerebrovascular disease; about onethird of these had some degree of paralysis. 16 The prevalence of cerebrovascular disease in households is higher among men than women at home in the U.S.A., partly because a greater proportion of disabled women leave WYLIE home to enter institutions. A particularly high prevalence group is the population known to have diabetes mellitus; its 2.3 million members include 76,000, or 3.3%, who have symptomatic cerebrovascular disease.
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Individual Factors Which Raise Incidence Rates
Many studies have shown that hypertension, atherosclerosis, heart -disease, diabetes mellitus, cigarette smoking in men, and taking oral contraceptives in women are conditions which are accompanied by a higher risk of dying from cerebrovascular disease.
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- 20 Most of these factors also increase the case-fatality ratio of hospital patients. 21 Tentative findings, from an ongoing study of cerebrovascular mortality in a volunteer population of over one million men and women, indicated that lack of exercise and long hours of sleep also raise the risk. 22 A study of longshoremen in California, by Paffenbarger et al., 28 did not support this belief. It gave preliminary evidence of higher death rates from coronary heart disease but not from stroke in less active men. To add to these findings, I shall now review some recently published incidence figures from Framingham. From the extensive data collected there, one publication makes it possible to correlate test results rather than diagnoses with the later development of cerebrovascular disease. 24 Table 5 presents a summary of these findings.
Clearly the tests which led to the diagnosis of hypertension related most closely to the likelihood of developing cerebrovascular disease. These tests included abnormal systolic or diastolic pressures, an abnormal electrocardiogram with left ventricular hypertrophy, an abnormal chest x-ray with heart enlargement or left ventricular hypertrophy, or a doubtful or positive urine albumin test These tests all raised markedly the subsequent frequency of cerebrovascular disease in Framingham.
The tests for serum cholesterol, phospho- lipid and uric acid performed poorly in separating off high incidence groups. Only slightly better, the blood glucose test gave tentative findings that low normal as well as high abnormal values might indicate a higher risk. A combination of two or more abnormal results of these tests would probably separate off higher risk groups, but would also miss many of those in whom cerebrovascular disease subsequently develops. Performing similarly was the urine sugar test, which did define a high risk group, but which also produced a negative result group in whom the incidence of disease was still relatively high.
Of considerable interest was the direct relationship between the hematocrit value and the subsequent frequency of disease in Framingham. Clearly one did not need to develop polycythemia vera before the hematocrit value showed an increased susceptibility to cerebrovascular disease. An epidemiological study in Wales supported this finding. In a population sample of 4,070 women, Elwood et al. 25 found that low hemoglobin values tended to be accompanied by low serum cholesterol levels, but had little association with blood pressure. Curing the anemia produced only a small rise in serum cholesterol, however. While unsure whether the relationship between low hemoglobin and low serum cholesterol levels was causal or not, the authors were tempted to conclude that mild anemia might slow the atherosclerotic process. This conclusion may fire some argument until it develops a stronger scientific base.
Such findings should guide the development of community programs for prevention and early detection of cerebrovascular disease, although studies have not yet progressed far enough to create a comprehensive and definitive list of risk factors. This is not crucial if one believes that conditions such as diabetes mellitus and essential hypertension should be strictly controlled, whether or not they are risk factors for stroke. Many physicians do not favor strict control, however, and must still be convinced that the benefits outweigh the potential risks. Epidemiological studies will lay a stronger foundation for preventive efforts when they clarify whether the treatment of earlier and asymptomatic conditions truly lowers the incidence of cerebrovascular disease. Such a study, recently completed for antihypertensive therapy, has produced hopeful results. 28 Another risk factor, the use of oral contraceptives, has been discussed mainly in relation to death statistics or to clinical case studies. Vessey and Doll 27 compared the use of oral contraceptives in British women in whom cerebral thrombosis developed with its use in carefully matched control patients. They estimated that the risk of development of a cerebral thrombosis was about six times higher in oral contraceptive users. In a retrospective study of patients hospitalized in the U.S.A., Sartwell et al. 28 found that 62% of a small group of cerebral thrombosis patients had used oral contraceptives within one month of onset of their illness, compared with 8% of control women. Inman et al. 29 found a positive correlation between the dose of estrogen and the risk of cerebral thrombosis. Certain discrepancies in the data suggest, however, that the dose of estrogen may not be the only factor relating to the risk of thromboembolism. 
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In a preliminary analysis, Kay et al. 80 found that oral contraceptive users in Britain were more likely also to be cigarette smokers, and to smoke heavily, than nonusers. The difference in smoking habits may exaggerate, they pointed out, the difference in disease frequency between users and nonusers. More recently in the U.S.A., Frederiksen and Ravenholt 81 calculated that women using oral contraceptives and smoking heavily had an incidence of thromboembolism 23 times that of women doing neither. While emphasizing the need for larger studies, they agreed that smoking may potentiate the role of oral contraceptives in causing thromboembolism. It now seems clear, therefore, that oral contraceptives play a definite but small part in the total range of factors predisposing to cerebrovascular disease. 32 Nevertheless, we must still determine how small that part is and the precise mechanism through which it occurs.
Community Care in the Acute State
In preparing a report for the President's Commission on Heart Disease, Cancer and Stroke, 88 the Health Economics Branch of the U. S. Public Health Service estimated the number of cerebrovascular disease discharges from general hospitals in the U.S.A. Table 6 presents their estimates for 1962, and contrasts them with annual discharge rates for Saskatchewan during 1961 through 1963.
The rates were reasonably close for ages under 65. The two older age groups, however, had discharge rates which were considerably lower for the United States than for Saskatchewan. It seems unlikely that these figures reflected different incidence rates for cerebrovascular disease in the two areas. More probable is that Saskatchewan hospitals admitted a higher proportion of all elderly patients with cerebrovascular disease, while many more of these patients in the United States went directly from home into nursing homes.
Hospital statistics for many geographical areas partly reflect the different arrangements and supply of facilities for community care. We have no way to decide, for example, whether many patients are hospitalized unnecessarily in Saskatchewan, or whether many elderly patients fail to get necessary hospital care in the U.S.A. Indeed, special studies of the two hospital systems will be needed to answer this question.
However, the belief is widely held, but poorly documented by scientific study in the U.S.A., that many general hospitals discourage the admission of stroke patients. Warren et al. 84 reviewed this problem in a study of emergency admissions to hospitals in London, England. Of 237 applicants with cerebrovascular disease, 48 were readily admitted, 83 were admitted with difficulty, and 106 were refused admission. The refusals were not necessarily wrong decisions, however, although the authors suggested that hospitals must more readily accept patients with acute exacerbations of chronic illness. Home care programs should also respond more swiftly to emergency calls, thus relieving some demands for hospital care. Lichty 86 has advocated the hospital as the logical place to begin care, but even hospital admission does not ensure a good diagnosis and optimal care. A recent study of the performance of 96 general hospitals in Michigan suggested that the quality of care given to stroke patients left much to be desired, and Data from reference 34. *In this particular study a teaching hospital was one which trained interns or residents, or both. 
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that improvement in quality may well reduce mortality in the hospital. 86 Of 20 tests which are often recommended in diagnosing cerebrovascular disease, the patients discharged from these hospitals received an average of nine. Table 7 summarizes the basic finding that the more diagnostic tests performed, the more likely were patients to be discharged alive. When groups of hospitals which performed the same number of tests were compared, those hospitals with interns and residents usually had the lower mortality, confirming that something more than increasing the testing effort is needed to improve care. One would expect the additional ingredients to be: (1) better followup of abnormal tests, (2) making more valid diagnoses, and (3) prescribing more specific treatments. Such steps would seem rational, but each will raise the cost of care. We must still assess whether the benefits will be worth the additional costs.
In a rather different retrospective study of 276 patients admitted to one hospital in California, Rashkind and Weiss 87 found that more than 46% had lesions which were operable by conservative criteria. The authors pointed out that such lesions would be missed without meticulous clinical evaluation and thorough diagnostic appraisal by all appropriate techniques, including angiography.
Community Care in the Long-Term Phase
If acute care becomes more effective in the future, more patients will survive to enter the long-term phase. As well as increasing the number of survivors, the further reduction in mortality will help survival of the more disabled and pathologically advanced patients who need more intensive and prolonged help from community health services and facilities.
Rehabilitative care offers a major source of hope for improvement in impaired patients. Unfortunately, many stroke patients in the past have delayed one year or more before seeking such care. 88 The few studies that relate earliness of care to the response to rehabilitation have been descriptive rather than experimental in nature.
89 Table 8 illustrates the findings of one descriptive study which suggested that the period of effort needed to produce improvement was considerably longer for late than for early admissions to a rehabilitation center. Perhaps the biggest question, still to be answered by future experiments, is how much of the better response in early rehabilitants is caused by the spontaneous remission which occurs soon after the onset of stroke.
Regarded by many physicians as part of good medical care, rehabilitation should ideally occur wherever the patients get their other necessary care. Many general hospitals, at least in the U.S.A., unfortunately, show no interest in rehabilitating those who overcome the barriers to admission. Even in a medical care program, which emphasized restoration, Falk et al. 40 showed that internists were slow to prescribe rehabilitative care for their stroke patients. Probably for some years to come, therefore, many patients will continue to leave the hospital without beginning an effective program of restorative care. Hospitals for chronic diseases, rehabilitation centers, and organized home care programs form alternative community resources to help with the more disabled patients.
It seems possible that rehabilitative care will help selected patients in many different locations in the community. More studies are needed, however, to show how difficult it is to find suitable patients in each place, and to determine how much and for how long the selected cases will benefit from rehabilitation. Much is now being done to clarify length of survival after reaching maximum benefit, and to determine those factors which help forecast length of survival.
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" 44 The introduction and strengthening of rehabilitative care in general hospitals probably deserve the most priority, since patients are thus obtained soon after onset. To help set such priorities, however, future studies must fill in the wide gaps which now exist in our current knowledge.
Health Manpower Problems
All manpower studies show that personnel are scarce in most geographical areas, affecting all health problems including cerebrovascular disease. One generalization is often used in manpower planning, however. This is that in fields where patient turnover is slower, it becomes feasible to use more shorter-trained personnel who provide care under the supervision of professionals. The long-term care of stroke patients should be one such field. 46 If trained in large numbers in the coming years, nonprofessionals will form the broad base of the hierarchy in long-term patient care, reporting to and supervised by professional therapists. They, in turn, have major decisions and advice given by neurologists, physiatrists, and other physicians. The professional therapists and physicians will inevitably be affected by the participation in patient care of large numbers of nonprofessionals. For example, physicians may have to allow the professional therapists to rise in status, to make more major decisions, and thus to provide a clearer place and more satisfying role for the nonprofessionals. Community planners who stimulate the training of more nonprofessionals may also have to help educate the existing health workers, who will adjust only with difficulty and some protest to this method of extending health services to larger population groups. This measure will be more than a temporary stopgap, however, for expanding the supply of longer-trained professionals will not be a viable alternative for some decades to come.
Conclusion
From this terse but lengthy paper it is possible 394 to see that many gaps exist in our current knowledge. However, it also shows that we now know enough about the incidence and community care of cerebrovascular disease for planning groups to make important decisions which will improve this field. We are constantly tempted to delay action until we collect more data from our own communities. We should now resist temptation, and act to raise the level of care for this long-neglected group of patients.
